INBIOMOTION S L has a total of 43 patent applications. It increased the IP activity by 12.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are SAGRES DISCOVERY, NAT BIO FOUNDER BIOTECHNOLOGY CO LTD and CAMH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Brazil | 4 | |
#6 | Canada | 4 | |
#7 | China | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Mexico | 3 | |
#10 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Measuring microorganism processes | |
#3 | Peptides | |
#4 | Medical preparations | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Gomis Roger | 36 |
#2 | Tercero Juan Carlos | 19 |
#3 | Coleman Robert E | 12 |
#4 | Gregory Walter Martin | 12 |
#5 | Jean-Mairet Joel | 8 |
#6 | Roger Gomis | 6 |
#7 | Juan Carlos Tercero | 5 |
#8 | Jean-Mairet Joël | 5 |
#9 | Walter Martin Gregory | 3 |
#10 | Robert E Coleman | 3 |
Publication | Filing date | Title |
---|---|---|
EP3713581A1 | Therapeutic treatment of breast cancer based on c-maf | |
KR20190021252A | Treatment of breast cancer based on c-MAF status | |
US2017121777A1 | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis | |
US2017369589A1 | Binding members for human c-MAF | |
WO2014184679A2 | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
AU2013328385A1 | Method for the diagnosis, prognosis and treatment of prostate cancer metastasis using c-MAF |